COMPARE · Data as of August 24, 2026
OMCL vs PRVA
Verdict: Side-by-side breakdown using the Bull Rankings model. OMCL scored 52.6, PRVA scored 56.3 — PRVA leads.
Compare another set
OMCL
Omnicell, Inc.
52.6
$34.66 · $1.6B
fundamentals as of
Score gap
3.7
PRVA leads
PRVA
Privia Health Group, Inc.
56.3
$21.02 · $2.7B
fundamentals as of
At a glance · who leads each dimension, on the model's own rules
- CheapestOMCL42.3x
- Fastest growthPRVA+24.1%
- Strongest balance sheetPRVA0.01
- Highest qualityOMCL48 / 100
- Largest discount to fair valuePRVA-14%
Side by side · every name on one set of axes
Growth against the P/E multiple. Up and to the right is cheaper and faster — the quality-growth idea in one picture. Points beyond the axis are pinned to the edge and marked off-scale rather than allowed to compress everything else.
The model, pillar by pillar (0–100 each)
OMCL
stronger →← stronger
PRVA
48
Qualityreturns · margins · balance sheet
45
59
Growthrevenue & earnings expansion
91
51
Valuevaluation vs sector peers
44
OMCL is stronger on 2 of 3 pillars.
Fundamentals, head-to-head
OMCL
PRVA
$143mC
FCF
$131mC
+8.5%B
Rev
+24.1%A-
0.15B+
D/E
0.01A
42.3xC
P/E
95.5xD
15.40D
PEG
4.46D
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
Valuation · DCF cross-check
OMCL
PRVA
11% below
Price vs fair valuelower is cheaper
14% below
~-4%/yr
Growth the price implies10-yr FCF · lower = less priced in
~9%/yr
+25%
1-yr DCF upside
-8%
+13%
5-yr DCF upside
+16%
-3%
10-yr DCF upside
+64%
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
Model signals
OMCL
No notable signals flagged.
PRVA
Why this score
- Diluting shareholders
The companies
OMCLOmnicell, Inc.
Why now
Health Information Services · market cap $1.6b. Down 37% from 52-week high of $55.00 — deep drawdown territory. 7 sell-side analysts publish a mean 1-yr target of $57.86 (implying +67% upside).
Moat
Free cash flow runs well ahead of reported net income — non-cash charges (depreciation, intangible amortization) are holding down GAAP earnings while cash generation stays strong.
Risk
Down 37% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up. Trailing P/E 42x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates. Net margin 3.1% is thin — operating leverage cuts both ways; input-cost inflation or pricing pressure hits the bottom line first.
PRVAPrivia Health Group, Inc.
Why now
Health Information Services · market cap $2.7b. Down 27% from 52-week high of $28.82 — deep drawdown territory. Revenue growing +24%, comfortably above the S&P median. 18 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $31.67 (implying +51% upside).
Moat
Free cash flow runs well ahead of reported net income — non-cash charges (depreciation, intangible amortization) are holding down GAAP earnings while cash generation stays strong.
Risk
Trailing P/E 95.5x prices in sustained high growth — any quarter that disappoints triggers sharp re-rating. Net margin 1.2% is thin — operating leverage cuts both ways; input-cost inflation or pricing pressure hits the bottom line first. ROE 4% is below the long-run sustainable threshold of ~10% — capital efficiency would need to improve for the equity base to compound at the market rate.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.
Where OMCL and PRVA diverge
On the headline score the gap is 3.7 points in favor of PRVA. They get there differently, though — each leads on a different pillar, so the better pick depends on which you weight.
- GrowthOMCL 59.5 · PRVA 91.1PRVA +31.6
- ValueOMCL 51.4 · PRVA 44.0OMCL +7.4
- QualityOMCL 47.5 · PRVA 44.6level
Pillars run 0–100 against sector peers, so a score is a statement about a company relative to its own industry rather than to the other name here. A wide Value gap usually means the market already prices the difference in quality or growth — which is the trade-off this comparison comes down to.